Navigation

  • Feed aggregator
    • Sources
logo

Search

Primary links

  • HOME
  • ABOUT US
    • Emerging Markets
  • services
    • Country & Site Selection
    • Regulatory
    • Site management
    • Clinical Monitoring
    • Medical Monitoring
    • Quality Assurance & Audits
    • Medical Translations
    • Trial Performance
  • Therapeutic Experience
  • countries
  • Patients & Sites
  • case studies
    • Cardiovascular Rescue
    • Atrial Fibrillation
    • Breast Cancer
  • contact

Sources

World Pharma News

  • Innovative ‘poop pills’ show promising results in clinical trials for multiple types of cancer 1 week 6 days old
  • Sanofi announces the signing of a share buyback mandate for up to €1 billion 2 weeks 4 hours old
  • How a heart medication could unlock a new targeted approach in lymphoma 2 weeks 1 day old
More

Biospace news

  • FDA Decision Tracker: Novo’s Once-Weekly Insulin Icodec Rejected 1 year 10 weeks old
  • Biopharma Layoff Tracker 2024: Spark, Novartis, Indivior and More Cut Staff 1 year 10 weeks old
  • PBMs and Big Pharma Play Blame Game for Inflated Prescription Drug Prices 1 year 10 weeks old
More
Syndicate content

World Pharma News

  • Innovative ‘poop pills’ show promising results in clinical trials for multiple types of cancer
  • Sanofi announces the signing of a share buyback mandate for up to €1 billion
  • How a heart medication could unlock a new targeted approach in lymphoma
  • A broken DNA repair tool accelerates aging
  • AstraZeneca begins trading on the New York Stock Exchange
more

© 2010 S&P Pharmaterra Management